309 related articles for article (PubMed ID: 26113417)
21. Underexpression and overexpression of Fas and Fas ligand: a double-edged sword.
Randhawa SR; Chahine BG; Lowery-Nordberg M; Cotelingam JD; Casillas AM
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):286-92. PubMed ID: 20408337
[TBL] [Abstract][Full Text] [Related]
22. The autoimmune lymphoproliferative syndrome: an experiment of nature involving lymphocyte apoptosis.
Fleisher TA
Immunol Res; 2008; 40(1):87-92. PubMed ID: 18193364
[TBL] [Abstract][Full Text] [Related]
23. Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome.
Agrebi N; Ben-Mustapha I; Matoussi N; Dhouib N; Ben-Ali M; Mekki N; Ben-Ahmed M; Larguèche B; Ben Becher S; Béjaoui M; Barbouche MR
Clin Immunol; 2017 Oct; 183():17-23. PubMed ID: 28668589
[TBL] [Abstract][Full Text] [Related]
24. FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.
Kuehn HS; Caminha I; Niemela JE; Rao VK; Davis J; Fleisher TA; Oliveira JB
J Immunol; 2011 May; 186(10):6035-43. PubMed ID: 21490157
[TBL] [Abstract][Full Text] [Related]
25. Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome.
Janda A; Schwarz K; van der Burg M; Vach W; Ijspeert H; Lorenz MR; Elgizouli M; Pieper K; Fisch P; Hagel J; Lorenzetti R; Seidl M; Roesler J; Hauck F; Traggiai E; Speckmann C; Rensing-Ehl A; Ehl S; Eibel H; Rizzi M
Blood; 2016 May; 127(18):2193-202. PubMed ID: 26907631
[TBL] [Abstract][Full Text] [Related]
26. Expression of Th17-related genes in PHA/IL-2-activated human T cells by Fas signaling via caspase-1- and Stat3-dependent pathway.
Su CC; Lin HC; Lin YP; Shan YS; Yang BC
Cell Immunol; 2013 Feb; 281(2):101-10. PubMed ID: 23590971
[TBL] [Abstract][Full Text] [Related]
27. Evolution of disease activity and biomarkers on and off rapamycin in 28 patients with autoimmune lymphoproliferative syndrome.
Klemann C; Esquivel M; Magerus-Chatinet A; Lorenz MR; Fuchs I; Neveux N; Castelle M; Rohr J; da Cunha CB; Ebinger M; Kobbe R; Kremens B; Kollert F; Gambineri E; Lehmberg K; Seidel MG; Siepermann K; Voelker T; Schuster V; Goldacker S; Schwarz K; Speckmann C; Picard C; Fischer A; Rieux-Laucat F; Ehl S; Rensing-Ehl A; Neven B
Haematologica; 2017 Feb; 102(2):e52-e56. PubMed ID: 27789675
[No Abstract] [Full Text] [Related]
28. Advances in autoimmune lymphoproliferative syndromes.
Madkaikar M; Mhatre S; Gupta M; Ghosh K
Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
[TBL] [Abstract][Full Text] [Related]
29. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
30. Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome.
Takagi M; Ogata S; Ueno H; Yoshida K; Yeh T; Hoshino A; Piao J; Yamashita M; Nanya M; Okano T; Kajiwara M; Kanegane H; Muramatsu H; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Bando Y; Kato M; Hayashi Y; Miyano S; Imai K; Ogawa S; Kojima S; Morio T
J Allergy Clin Immunol; 2017 Jun; 139(6):1914-1922. PubMed ID: 27845235
[TBL] [Abstract][Full Text] [Related]
31. Synergistic defects of novo FAS and homozygous UNC13D leading to autoimmune lymphoproliferative syndrome-like disease: A 10-year-old Chinese boy case report.
Gu H; Ma J; Chen Z; Wang J; Zhang R; Wu R
Gene; 2018 Sep; 672():45-49. PubMed ID: 29864493
[TBL] [Abstract][Full Text] [Related]
32. Monogenic defects in lymphocyte apoptosis.
Fleisher TA; Oliveira JB
Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):609-15. PubMed ID: 22918222
[TBL] [Abstract][Full Text] [Related]
33. Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.
Pellé O; Moreno S; Lorenz MR; Riller Q; Fuehrer M; Stolzenberg MC; Maccari ME; Lenoir C; Cheminant M; Hinze T; Hebart HF; König C; Schvartz A; Schmitt Y; Vinit A; Henry E; Touzart A; Villarese P; Isnard P; Neveux N; Landman-Parker J; Picard C; Fouyssac F; Neven B; Grimbacher B; Speckmann C; Fischer A; Latour S; Schwarz K; Ehl S; Rieux-Laucat F; Rensing-Ehl A; Magérus A
J Allergy Clin Immunol; 2024 Jan; 153(1):203-215. PubMed ID: 37793571
[TBL] [Abstract][Full Text] [Related]
34. A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.
Aruna BV; Ben-David H; Sela M; Mozes E
Immunology; 2006 Jul; 118(3):413-24. PubMed ID: 16827902
[TBL] [Abstract][Full Text] [Related]
35. FAS Haploinsufficiency Caused by Extracellular Missense Mutations Underlying Autoimmune Lymphoproliferative Syndrome.
de Bielke MG; Perez L; Yancoski J; Oliveira JB; Danielian S
J Clin Immunol; 2015 Nov; 35(8):769-76. PubMed ID: 26563159
[TBL] [Abstract][Full Text] [Related]
36. Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia.
Rensing-Ehl A; Janda A; Lorenz MR; Gladstone BP; Fuchs I; Abinun M; Albert M; Butler K; Cant A; Cseh AM; Ebinger M; Goldacker S; Hambleton S; Hebart H; Houet L; Kentouche K; Kühnle I; Lehmberg K; Mejstrikova E; Niemeyer C; Minkov M; Neth O; Dückers G; Owens S; Rösler J; Schilling FH; Schuster V; Seidel MG; Smisek P; Sukova M; Svec P; Wiesel T; Gathmann B; Schwarz K; Vach W; Ehl S; Speckmann C
Haematologica; 2013 Dec; 98(12):1948-55. PubMed ID: 23850805
[TBL] [Abstract][Full Text] [Related]
37. Defective apoptosis in lymphocytes and the role of IL-2 in autoimmune hematologic cytopenias.
Shenoy S; Mohanakumar T; Chatila T; Tersak J; Duffy B; Wang R; Thilenius AR; Russell JH
Clin Immunol; 2001 May; 99(2):266-75. PubMed ID: 11318598
[TBL] [Abstract][Full Text] [Related]
38. Participation of FLIP, RIP and Bcl-x(L) in Fas-mediated T-cell death.
Djerbi M; Malinowski MM; Yagita H; Zhivotovsky B; Grandien A
Scand J Immunol; 2007 Oct; 66(4):410-21. PubMed ID: 17850585
[TBL] [Abstract][Full Text] [Related]
39. Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome.
Rieux-Laucat F
Curr Dir Autoimmun; 2006; 9():18-36. PubMed ID: 16394653
[TBL] [Abstract][Full Text] [Related]
40. Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome.
Consonni F; Moreno S; Vinuales Colell B; Stolzenberg MC; Fernandes A; Parisot M; Masson C; Neveux N; Rosain J; Bamberger S; Vigue MG; Malphettes M; Quartier P; Picard C; Rieux-Laucat F; Magerus A
Cell Death Dis; 2024 May; 15(5):315. PubMed ID: 38704374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
